Evidence map›Paper›PMID 33168500›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Silencing of SLP-2 inhibits the migration and invasion of cervical cancer cells

Jialu Zhang, Guolin Hu, Lei Liu, Huodi Chen, Danjuan Li, Weijiang Liang

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jialu ZhangDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Guolin HuDepartment of Oncology, Qingyuan People's Hospital, Qingyuan 511500, China.
Lei LiuDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Huodi ChenDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Danjuan LiDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Weijiang LiangDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of SLP-2 silencing on the migration and invasion of human cervical cancer cells and explore the mechanism.

methodsSmall interfering RNA (siRNA) was used to knockdown the expression of SLP-2 in Hela cells and Siha cells. At 48 h after the transfection, the cells were examined for SLP-2 expression with Western blotting, and wound healing assay and Transwell assay were used to evaluate the changes in the cell migration; Matrigel Transwell assay was used to evaluate the changes in the invasion ability of the cells. The expressions of E-cadherin, β-catenin, vimentin and Twist in Hela and Siha cells following the transfection were detected with Western blotting.

resultsCompared with the control cells, siRNA transfection significantly lowered the expression of SLP-2 and suppressed the migration and invasion ability of Hela cells and Siha cells (

conclusionsSilencing SLP-2 via siRNA transfection can inhibit epithelial-mesenchymal transition of human cervical cancer cells and lower their migration and invasion abilities possibly in relation with downregulated expression of Twist.

Indexed as

cervical cancerepithelial-mesenchymal transitioninvasionmigrationSLP-2

Identifiers

PMID33168500
PMCPMC6765530
OpenAlexW3104612526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.